- Home
- GRNT vs VALN Comparison
GRNT vs VALN Comparison
Compare GRNT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRNT
- VALN
- Stock Information
- Founded
- GRNT 2013
- VALN 2012
- Country
- GRNT United States
- VALN France
- Employees
- GRNT N/A
- VALN N/A
- Industry
- GRNT Blank Checks
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRNT Finance
- VALN Health Care
- Exchange
- GRNT Nasdaq
- VALN Nasdaq
- Market Cap
- GRNT 707.4M
- VALN 777.9M
- IPO Year
- GRNT N/A
- VALN 2021
- Fundamental
- Price
- GRNT $5.53
- VALN $9.97
- Analyst Decision
- GRNT Buy
- VALN Strong Buy
- Analyst Count
- GRNT 2
- VALN 4
- Target Price
- GRNT $7.50
- VALN $15.75
- AVG Volume (30 Days)
- GRNT 529.9K
- VALN 120.7K
- Earning Date
- GRNT 11-06-2025
- VALN 11-06-2025
- Dividend Yield
- GRNT 7.93%
- VALN N/A
- EPS Growth
- GRNT N/A
- VALN N/A
- EPS
- GRNT 0.25
- VALN N/A
- Revenue
- GRNT $409,332,000.00
- VALN $230,566,060.00
- Revenue This Year
- GRNT $34.49
- VALN $14.76
- Revenue Next Year
- GRNT $13.97
- VALN $24.11
- P/E Ratio
- GRNT $22.56
- VALN N/A
- Revenue Growth
- GRNT 10.32
- VALN 25.47
- 52 Week Low
- GRNT $4.52
- VALN $3.62
- 52 Week High
- GRNT $7.00
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- GRNT 53.96
- VALN 59.97
- Support Level
- GRNT $5.31
- VALN $8.72
- Resistance Level
- GRNT $5.47
- VALN $9.19
- Average True Range (ATR)
- GRNT 0.17
- VALN 0.35
- MACD
- GRNT 0.01
- VALN -0.03
- Stochastic Oscillator
- GRNT 65.69
- VALN 96.14
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.